Skip to main content
2025 DC/CSEM Professional Conference Main banner

Rémi Rabasa-Lhoret, MD, PhD (he/him/his)

Endocrinologist & Associate Professor
IRCM, CHUM
Montreal, Quebec, Canada

Rémi Rabasa-Lhoret is vice-president (clinical and clinical research) at the IRCM, a medical doctor in the endocrinology division of the CHUM, and a professor of medicine and nutrition at the University of Montreal. He holds 4 diabetes research chairs and has received numerous awards and fellowships. His team holds large national and international funds, has published over 400 manuscripts, and has contributed to national and international treatment recommendations. He is also director of the professional section of diabetes Québec and a member of the Canadian Academy of Health Sciences. The main objective of his team's research program is to reduce the burden of hypoglycemia for patients with type 1 diabetes. He was one of the pioneers in the development of the artificial pancreas. He also studies the causes and consequences of diabetes in patients living with cystic fibrosis.

Disclosure(s): 35Pharma Inc: Advisory Board (Ongoing); Abbott: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing); Insulet: Advisory Board (Ongoing); Novo-Nordisk: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Sanofi-Aventis: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Ypsomed: Advisory Board (Ongoing)

Presentation(s):